Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling
2020 · Annals of the Rheumatic Diseases · 27 citations
https://doi.org/10.1136/annrheumdis-2019-216847
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
165
Citations
4
h-index
3
i10-index
Lars Godmann is an academic researcher. The author has contributed to research in topics: Osteoarthritis Treatment and Mechanisms & Proteoglycans and glycosaminoglycans research & Immune Response and Inflammation. The author has an h-index of 4, co-authored 17 publications.
Click to start Chat